{"disease":{"id":"stroke-patient","name":"stroke patient"},"drugs":{"marketed":[{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"no-oac","indication_name":"Atrial Fibrillation or Flutter with a High Risk of Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF and at Least One Risk Factor for Stroke in Patients with a History of Stroke, TIA, or Non-Valvular AF","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"No OAC","generic_name":"no-oac","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Factor Xa","drug_class":"Direct Oral Anticoagulant","quality_score":45,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03734640","title":"Optimal Post Tpa-Iv Monitoring in Ischemic Stroke","phase":"NA","overall_status":"COMPLETED","enrollment_count":4922,"lead_sponsor_name":"Craig Anderson","has_results":false},{"nct_id":"NCT04000971","title":"Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":1198,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT07294209","title":"Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":798,"lead_sponsor_name":"Southwest Hospital, China","has_results":false},{"nct_id":"NCT07014501","title":"Study on the Correlation Mechanism and Application of Genetic Susceptibility, Hemoglobin Adaptation Changes, and Extubation Success Rate in Stroke Patients With Tracheotomy at Different Altitudes","phase":"","overall_status":"RECRUITING","enrollment_count":717,"lead_sponsor_name":"The Second Affiliated Hospital of Kunming Medical University","has_results":false},{"nct_id":"NCT05907694","title":"Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure","phase":"NA","overall_status":"RECRUITING","enrollment_count":714,"lead_sponsor_name":"Josep Rodes-Cabau","has_results":false},{"nct_id":"NCT07253181","title":"Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":572,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT06817642","title":"Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing.","phase":"","overall_status":"RECRUITING","enrollment_count":570,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07231380","title":"A Comparison of Cyclic Manual Direct Aspiration Thrombectomy (Plunger Technique) vs. Static Manual Direct Aspiration Thrombectomy for Treatment of Acute Large Vessel Occlusion Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06623253","title":"Survey Stroke Units in Argentina","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Hospital de Rehabilitacion Manuel Rocca","has_results":false},{"nct_id":"NCT03217279","title":"Needs Assessment and Quality of Life of Stroke Patients and Their Caregivers","phase":"","overall_status":"COMPLETED","enrollment_count":396,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03228251","title":"Simulation-based Training of Rapid Evaluation and Management for Acute Stroke (STREAM) Trial","phase":"","overall_status":"COMPLETED","enrollment_count":379,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT03335995","title":"Stroke Prognosis in Intensive CarE","phase":"","overall_status":"COMPLETED","enrollment_count":364,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06731673","title":"Heat Shock Protein 47 in Thrombosis","phase":"","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06878066","title":"Thrombolysis in Factor Xa-inhibitors Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Guri Hagberg","has_results":false},{"nct_id":"NCT07524036","title":"Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07416734","title":"RCT of HeartBot in Women","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06943014","title":"Development and Validation of an Actimetric Protocol to Quantify Physical Activity and Sedentary Behaviour in Post-stroke Subjects","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT05076565","title":"Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shirley Ryan AbilityLab","has_results":false},{"nct_id":"NCT07360899","title":"Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Institute of Cardiovascular Diseases, Vojvodina","has_results":false},{"nct_id":"NCT05291442","title":"Improving Resilience and Quality of Life of Stroke Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT06519227","title":"Translation and Validation of Rivermead Mobility Index in Urdu","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT05727358","title":"Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"PLA Rocket Force Characteristic Medical Center","has_results":false},{"nct_id":"NCT05282290","title":"Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT07001267","title":"Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT04029701","title":"Clinical Observation on the Treatment of Motor and Sensory Dysfunction After Stroke With Ruyizhenbao Pill","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT07478042","title":"Guiding Catheters in Endovascular Stroke Therapy - Are Balloon Guided Catheters Superior?","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University Hospital Heidelberg","has_results":false},{"nct_id":"NCT07372326","title":"A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":105,"lead_sponsor_name":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT07011095","title":"DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT07277595","title":"kTMP in Chronic Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02354248","title":"Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Brugmann University Hospital","has_results":false},{"nct_id":"NCT06999876","title":"The Effect of Combined Transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) on Lower Limb Motor Function in Subacute to Chronic Stroke Patients With Hemiplegia (COMPENSATOR-Stroke)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"National University Health System, Singapore","has_results":false},{"nct_id":"NCT06258538","title":"Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Control, Motor and Daily Functions, and Quality of Life After Stroke","phase":"NA","overall_status":"RECRUITING","enrollment_count":87,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07282106","title":"Effect of Transcutaneous Auricular Stimulation of the Vagus Nerve on Functional Connectivity in the Brain at Rest","phase":"NA","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Clinique Les Trois Soleils","has_results":false},{"nct_id":"NCT04877171","title":"Telemedicine Efficacy in Medication Adherence in Post-ischemic Stroke Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Fundación Cardiovascular de Colombia","has_results":false},{"nct_id":"NCT05741086","title":"Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT04196322","title":"Hyperglycemia as a Prognostic Factor In Acute Ischemic Stroke Patients","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT06885502","title":"Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Eodyne Systems SL","has_results":false},{"nct_id":"NCT06787508","title":"Exploration of Repeated High-frequency Transcranial Magnetic Stimulation for the Treatment of Acute Phase Aphasia in Post-stroke Patients","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":70,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT04236089","title":"Compare Effects of the Mirror Therapy and Robotic Mirror Therapy in Electroencephalography of Healthy Adults and Stroke Patients.","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06974461","title":"Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"The Hong Kong Polytechnic University","has_results":false},{"nct_id":"NCT07236216","title":"Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT06921031","title":"Stroke Patients' Preferences for an Exoskeleton for Lower Limb Rehabilitation Using the DCE Method (EXOPREF)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04468269","title":"Task-oriented Balance Training With Sensory Integration","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07074600","title":"Clinical Efficacy of Electroacupuncture Therapy on Limb Dysfunction in Ischemic Stroke Patients at High-Altitude Regions: A Multi-center Randomized Double-blind Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Kaiyang Zheng","has_results":false},{"nct_id":"NCT06673771","title":"Effects of Vestibular Rehabilitation on Balance and Post Stroke Fatigue :","phase":"NA","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT06762249","title":"Combined Effect of CIMT and Brunnstrom Therapy on UE in Stroke Patients","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":56,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT07484438","title":"Effects of Task Oriented Gait Training With Core Stablization Excercises on 3 Parameters.","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT06878677","title":"Individualized Exercise Prescription With a Data-driven Approach in Individuals With Stroke","phase":"NA","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"The Hong Kong Polytechnic University","has_results":false},{"nct_id":"NCT06951035","title":"Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT07439367","title":"Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"School of Health Sciences Geneva","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}